Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMARTTT 2.0: Contingency Management for Smoking Cessation in Persons with HIV
NCT07835555Phase 4Not yet recruiting
- Sponsor
- Yale University
- Start
- Sep 2027
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by Yale University. Primary endpoint: 7-day point-prevalence abstinence confirmed by exhaled carbon monoxide (eCO) at 12 weeks. Planned start Sep 2027; status: not yet recruiting.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT07835555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07835555.